Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q2 2026 · 10-Q
Revenue$36.93M$36.93M+2.6% vs Q2 2025 Net Income$3.23M$3.23M+24.3% vs Q2 2025 EPS Diluted$0.15$0.15+25.0% vs Q2 2025 Gross Profit$21,413,000+7.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flowderived$6,777,000−3.3% Free Cash Flowderived$6,686,000−1.6% Margins · derivedGross margin58.0%+2.8 pt vs Q2 2025
Operating margin11.2%+0.8 pt vs Q2 2025
Net margin8.7%+1.5 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 4, 2026 · 35 d after period end